HomeCONGRESSInternational Congresses

International Congresses

OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.

Extending dual antiaggregation therapy (DAT) from 12 to 48 months appears not to offer extra protection after...

Meta-analysis of prolonged DAT after DES

Extending the antiaggregation therapy over a year reduces adverse events in patients with a history of AMI,...

FAME at 5 years: FFR Should Guide All Multivessel PCIs

Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first...

BACC: Protocol for Rapid Diagnosis of Myocardial Infraction

The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe. To carry out the...

TCT 2015

Encuentre la cobertura del Transcatheter Cardiovascular Therapeutics TCT 2015, que se realizó del 11 al 15 de octubre...

BRAVO 3: Heparina vs Bivalirudina en pacientes que reciben TAVI

Original article Thierry Lefevre